Clayton Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13
Closed -$3.81K 227
2026
Q1
$3.81K Hold
13
﹤0.01% 357
2025
Q4
$4.56K Buy
+13
New +$4.39K ﹤0.01% 317

Other funds holding ELV

Clayton Financial Group's ELV Position: Q2 2026 in Review

Clayton Financial Group sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 13 shares — an estimated $3.81K sold.

Clayton Financial Group first reported a position in ELV in Q4 2025 and held it in 2 quarters. The position peaked at $4.56K in Q4 2025. 594 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Clayton Financial Group reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Clayton Financial Group sold 13 Elevance Health shares in Q2 2026, an estimated $3.81K.
  • Clayton Financial Group first reported a position in Elevance Health in Q4 2025 and held it in 2 quarters.
  • Clayton Financial Group's Elevance Health position peaked at $4.56K in Q4 2025.
  • 594 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.